Fierce Biotech June 10, 2024
Against a backdrop of low-volume but growing concerns about bird flu, the National Institutes of Health’s (NIH’s) infectious disease arm has laid out its plans to study the virus that causes the illness.
In a document (PDF) released publicly June 5, the NIH’s National Institute of Allergy and Infectious Diseases (NIAID) explained that it planned to track the H5N1 virus’s evolution, study its clinical course and come up with prevention, diagnostic and treatment strategies.
The agenda “hits on all the right issues,” Nigel Sizer, Ph.D., executive director of the Preventing Pandemics at the Source initiative, told Fierce Biotech Research in an email.
The new effort builds upon existing work, Sizer pointed out. Even before the virus was discovered in...